High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma

Tumour Biol. 2016 Oct;37(10):13659-13667. doi: 10.1007/s13277-016-5204-x. Epub 2016 Jul 29.

Abstract

Prognosis of cholangiocarcinoma (CCA) patients is absolutely poor in spite of extensive efforts for the development of chemotherapy. Mitochondrial proteins play key roles in carcinogenesis of various cancers. Therefore, mitochondria are considered as the target organelles for chemotherapy of several cancers including CCA. The purpose of this study is to identify potential candidate proteins for chemotherapy using mitochondrial proteome analysis for CCA tissues. A shotgun proteomic approach using SDS-PAGE coupled with LC-MS/MS was applied to compare the expression of mitochondrial proteins in CCA and the adjacent non-cancerous tissues. Using the proteomic analysis for the pooled mitochondrial proteins purified from three each of papillary and non-papillary types of CCA and their adjacent tissues, 281 proteins were identified as mitochondrial proteins, and 105 of them have significantly different expression levels compared with the corresponding counterparts. Among the 105 proteins, apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) was a unique protein commonly over-expressed in both papillary and non-papillary types of CCA tissues but not in the adjacent non-cancerous tissues. In conclusion, AIFM3 was aberrantly expressed only in the mitochondria of CCA tissues. This finding suggests that AIFM3 could be a potential target molecule for CCA chemotherapy.

Keywords: Apoptosis-inducing factor; Cholangiocarcinoma; Mass spectrometry; Mitochondrial proteins.

MeSH terms

  • Apoptosis Inducing Factor / metabolism*
  • Bile Duct Neoplasms / metabolism*
  • Bile Duct Neoplasms / pathology
  • Bile Ducts, Intrahepatic / metabolism*
  • Bile Ducts, Intrahepatic / pathology
  • Biomarkers, Tumor / metabolism*
  • Blotting, Western
  • Case-Control Studies
  • Cholangiocarcinoma / metabolism*
  • Cholangiocarcinoma / pathology
  • Follow-Up Studies
  • Humans
  • Immunoenzyme Techniques
  • Neoplasm Staging
  • Prognosis
  • Proteomics / methods
  • Tandem Mass Spectrometry
  • Xenograft Model Antitumor Assays

Substances

  • Apoptosis Inducing Factor
  • Biomarkers, Tumor